期刊文献+

软组织磷酸盐尿性间叶肿瘤的临床病理分析 被引量:15

Clinicopathological features of phosphaturic mesenchymal tumor of soft tissue
下载PDF
导出
摘要 目的研究磷酸盐尿性间叶肿瘤(混合结缔组织亚型)的临床与病理学特点。方法对1例骨软化症患者的肿块切除标本进行光镜、电镜和免疫组化SP法检测。结合临床资料,并复习相关文献。结果患者表现为顽固性骨软化症、低磷酸盐血症,高磷酸盐尿,高血清碱性磷酸酶,外周血单核细胞增多,血钙浓度正常。经99mTc-OCT(奥曲肽)检查指导临床发现左腘窝区小肿块并切除之。术后3天,血磷恢复正常。光镜下肿瘤主要由肥胖的梭形细胞和破骨细胞样多核巨细胞构成,具有丰富的血管,可见血管外皮瘤样血管、散在脂肪岛、明显的出血及含铁血黄素沉积,肿瘤边缘有不完整的膜状骨样或软骨样组织。电镜下见梭形细胞内含数量不等的细颗粒状电子致密物,其中部分为结晶样高电子致密度颗粒。免疫组化显示多核细胞和单核间质细胞CD68阳性。结论该例为肿瘤源性骨软化症,其病理类型为磷酸盐尿性间叶肿瘤,混合结缔组织亚型。外科切除后治愈,99mTc-OCT对于指导临床发现小的隐蔽病灶很有价值。 Purpose To study the clinical and pathological features of the phosphaturic mesenchymal tumor, mixed connective tissue variant(PMT/MCT). Methods The tumor resected from a patient with osteomalacia was studied by light and electron microscopy and immunohistochemistry, and the related literature was reviewed as well Results The clinical feature was intractable osteomalacia characterized by hypophosphatemia, phosphaturia, elevated serum alkaline phosphatase, monocytosis, and normal serum concentrations of calcium. 99mTc-OCT examination suggested that the tumor was located in the left popliteal fossa, and three days after remove of the tumor, the serum phosphate level returned to normal. Microscopically, the tumor was primarily composed of numerous plump spindle cells and osteoclast-like giant cells, and was rich in vasculature. In addition, there were scattered islands of mature adipocytes, hemangiopericytoma-like vessels, osteoid and calcified cartilage-like tissue, hemorrhage and obvious hemosiderin deposition were observed as well. The tumor had no border, and an incomplete rim of membranous osteoid or cartilage-like tissue could be seen. Under electron microscope, micro-granular electron-dense matter was seen in the spindle cells, some were crystal-like, which were either free or combined with lysosome. No neuroendocrine granule was found. The tumor cells expressed CD68, α-SMA and vimentin, whereas they were negative for all other markers. Conclusions The case reported here is an oncogenic osteomalacia, and its histopathologic type is PMT/MCT. Surgical resection can effectively cure the disease, and 99mTc-OCT is valuable to show the location of the tumor even if the tumor is small and occult.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2007年第5期557-561,共5页 Chinese Journal of Clinical and Experimental Pathology
关键词 肿瘤源性骨软化症 磷酸盐尿性间叶肿瘤 低磷酸盐血症 高磷酸盐尿 99mTc-OCT oncogenic osteomalacia phosphaturic mesenchymal tumor hypophosphatemia phosphaturia 99 mTc-OCT
  • 相关文献

参考文献17

  • 1Folpe A L, Fanburg-Smith J C, Billings S D, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature[J]. Am J Surg Pathol, 2004, 28(1) :1 -30.
  • 2De Beur S M, Finnegan R B, Vassiliadis J, et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism[J]. J Bone Miner Res, 2002, 17(6) : 1102 - 10.
  • 3John M R, Wickert H, Zaar K, et al. A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma [J]. Bone, 2001, 29(4):393 -402.
  • 4Nelson A E, Hogan J J, Holm I A, et al. Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties[J]. Bone, 2001, 28(4) :430 -9.
  • 5Bowe A E, Finnegan R, Jan de Beur S M, et al. FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate [J]. Biochem Biophys Res Commun, 2001, 284(4) :977 - 81.
  • 6Mirams M, Robinson B G, Mason R S, et al. Bone as a source of FGF23 : regulation by phosphate? [J]. Bone, 2004, 35(5): 1192 -9.
  • 7Larsson T, Zahradnik R, Lavigne J, et al. Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia[J]. Eur J Endocrinol, 2003, 148 (2) :269 - 76.
  • 8Zimering M B, Caldarella F A, White K E, et al. Persistent tumor-induced osteomalacia confirmed by elevated postoperative levels of serum fibroblast growth factor-23 and 5-year follow-up of bone density changes [J]. Endocr Pract, 2005, 11 (2): 108 - 14.
  • 9Gonzalez-Compta X, Manos-Pujol M, Foglia-Fernandez M, et al. Oncogenic osteomalacia: case report and review of head and neck associated tumours[J]. J Laryngol Otol, 1998, 112(4):389 - 92.
  • 10Sakamoto A, Oda Y, Nagayoshi Y, et al, Glomangiopericytoma causing oncogenic osteomalacia, A case report with immunohistochemical analysis[J]. Arch Orthop Trauma Surg, 2001, 121 (1-2) :104 -8.

同被引文献139

引证文献15

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部